FDA Inspection 598198 — Sentry Biopharma Services, Inc.

Sentry Biopharma Services, Inc. — FEI 3007066137

The FDA completed an inspection of Sentry Biopharma Services, Inc. on July 22, 2009 in Indianapolis, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 22, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Indianapolis, IN (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
172221 CFR 211.134(a)Correct labels during finishing operations